"10.1371_journal.pone.0048463","plos one","2012-11-08T00:00:00Z","Abhishek K Srivastava; Rajesh K Sharma; Esma S Yolcu; Vahap Ulker; Kathryn MacLeod; Gunes Dinc; Haval Shirwan","Institute for Cellular Therapeutics, Department of Microbiology and Immunology and James Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America; ApoVax Inc., Louisville, Kentucky, United States of America","Conceived and designed the experiments: AKS RKS ESY VU KM HS. Performed the experiments: AKS RKS ESY VU KM GD. Analyzed the data: AKS RKS ESY VU KM GD HS. Wrote the paper: AKS RKS ESY HS.","The SA-4-1BBL described in this manuscript is licensed from U of L by ApoVax, Inc., Louisville, Kentucky, for which HS serves as CSO and member of the Board of Directors, and HS and ESY have significant equity interest in the company. The other authors disclosed no potential conflict of interest. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors..","2012","11","Abhishek K Srivastava","AKS",7,TRUE,6,6,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
